CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI)

27 filings reported holding CASI - CASI Pharmaceuticals, Inc. - Ordinary Shares as of Q3 2024.
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,322,529 shares of 20,761,963 outstanding shares and own 6.37% of the company stock.
Largest 10 shareholders include VR Adviser, LLC (987,259 shares), Wellington Shields Capital Management, LLC (89,217 shares), ADAR1 Capital Management, LLC (64,835 shares), Wellington Shields & Co., LLC (43,091 shares), RENAISSANCE TECHNOLOGIES LLC (41,500 shares), Woodline Partners LP (30,532 shares), CITADEL ADVISORS LLC (22,714 shares), GEODE CAPITAL MANAGEMENT, LLC (19,363 shares), UBS Group AG (14,681 shares), and Royal Bank of Canada (6,900 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.